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INTRODUCTION
In the fast-moving business world, firms are highly competing among 
them. In general, we believe that finance covers three main topics that are 
capital budgeting, capital structure, and working capital management. 
Capital budgeting and capital structures are associated with investment 
decisions while working capital management is the functional area of 
finance. It involves the relationship between a firm’s short-term assets 
and its short-term liabilities such as managing inventories, accounts 
receivable and payable, and case [4]. The main purpose of any firm is 
to maximize profit. However, maintaining liquidity of the firm also is 
an important objective. Hence, liquidity and profitability are both the 
two different sides of the same coin. The problem is that increasing 
profits at the cost of liquidity can bring serious problems to the firm. 
Thus, the strategy of the firm must maintain a balance between these 
two objectives of the firm. Dilemma in working capital management 
is to achieve the desired trade-off between liquidity and profitability. 
Referring to the theory of risk and return, an investment with more risk 
will result in more return. Thus, firms with high liquidity of working 
capital may have low risk and low profitability. Conversely, a firm that 
has low liquidity of working capital faces high risk; this result leads 
to high profitability. Although this might increase profitability (due to 
increase sales), if may also adversely affect the profitability if the costs 
tied up working capital exceed the benefits of holding more inventory 
and/or granting more trade credit to customers.
ABOUT THE INDIAN PHARMACEUTICAL INDUSTRY
Introduction
The Indian pharmaceuticals market is the third largest in terms of 
volume and 13th largest in terms of value, and it accounts for 20% in 
the volume terms and 1.4% in value terms of the Global Pharmaceutical 
Industry as per a report by Equity Master. India is the largest provider 
of generic drugs globally with the Indian generics accounting for 20% 
of global exports in terms of volume. Of late, consolidation has become 
an important characteristic of the Indian pharmaceutical market as the 
industry is highly fragmented.
India enjoys an important position in the global pharmaceuticals sector. 
The country also has a large pool of scientists and engineers who 
have the potential to steer the industry ahead to an even higher level. 
Presently, over 80% of the antiretroviral drugs used globally to combat 
Acquired Immuno Deficiency Syndrome (AIDS) are supplied by Indian 
pharmaceutical firms.
The UN-backed Medicines Patent Pool has signed six sub-licenses 
with Aurobindo, Cipla, Desano, Emcure, Hetero Labs, and Laurus 
Labs, allowing them to make generic anti-AIDS medicine Tenofovir 
alafenamide for 112 developing countries.
Market size
The Indian pharma industry, which is expected to grow over 15% per 
annum between 2015 and 2020, will outperform the global pharma 
industry, which is set to grow at an annual rate of 5% between the 
same period! The market is expected to grow to US$ 55 billion by 2020, 
thereby emerging as the sixth largest pharmaceutical market globally 
by absolute size, as stated by Mr. Arun Singh, Indian Ambassador 
to the US. Branded generics dominate the pharmaceuticals market, 
constituting nearly 80% of the market share (in terms of revenues). 
The sector is expected to generate 58,000 additional job opportunities 
by the year 2025. 
India’s pharmaceutical exports stood at US$ 16.4 billion in 2016–2017 
and are expected to grow by 30% over the next 3 years to reach US$ 
20 billion by 2020, according to the Pharmaceuticals Export Promotion 
Council of India.
Indian companies received 55 Abbreviated New Drug Application 
(ANDA) approvals and 16 tentative approvals from the US Food and 
Drug Administration (USFDA) in Q1 of 2017. The USFDA approvals are 
expected to cross 700 ANDA in 2017, thereby recording a year-on-year 
growth of 17%. The country accounts for around 30% (by volume) and 
about 10% (value) in the US$ 70–80 billion US generics market.
India’s biotechnology industry comprising bio-pharmaceuticals, bio-
services, bio-agriculture, bio-industry, and bioinformatics is expected 
grow at an average growth rate of around 30% a year and reach US$ 
100 billion by 2025. Biopharma, comprising vaccines, therapeutics, and 
diagnostics are the largest sub-sector contributing nearly 62% of the 
total revenues at Rs 12,600 crore (US$ 1.89 billion).
Investments
The Union Cabinet has given its nod for the amendment of the existing 
Foreign Direct Investment (FDI) policy in the pharmaceutical sector to 
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allow FDI up to 100% under the automatic route for manufacturing of 
medical devices subject to certain conditions.
The drugs and pharmaceuticals sector attracted cumulative FDI inflows 
worth US$ 14.71 billion between April 2000 and March 2017, according 
to data released by the department of industrial policy and promotion.
Some of the major investments in the Indian pharmaceutical sector are 
as follows:
•	 The	exports	of	Indian	pharmaceutical	industry	to	the	US	will	get	a	
boost in FY18, as branded drugs worth US$ 50 billion will become 
off-patented.#
•	 Private	 equity	 (PE)	 and	 venture	 capital	 investments	 in	 the	
pharmaceutical sector have grown at 38% year-on-year between 
January 2017 and June 2017, due to major deals in this sector.
•	 Indian	pharmaceutical	firm,	Eric	Lifesciences	Pvt.,	Ltd.,	has	launched	
its initial public offering worth Rs. 2000 crore (US$ 311 million) in 
June 2017.
•	 Indian	pharmaceutical	company,	Cadila	Healthcare	Ltd.,	is	planning	
to	 raise	Rs.	 1000	 crore	 (US$	 155	million)	 through	 a	 qualified	
institutional placement of shares shortly.
•	 Capital	International	Group,	a	PE	fund,	has	acquired	a	3%	stake	in	
Intas Pharmaceuticals Ltd. from ChrysCapital Llc for a consideration 
of US$ 107 million, thereby valuing Intas Pharma at approximately 
US$ 3.5 billion.
•	 Aurobindo	Pharma	Ltd.	 has	 acquired	 four	 biosimilar	 products	
from	Swiss	 firm	TL	Biopharmaceutical	AG,	which	will	 require	TL	
Biopharmaceutical to supply all the developmental data for four 
molecules, which will be developed, commercialized and marketed 
by Aurobindo Pharma.
•	 Piramal	Enterprises	Ltd.	acquired	a	portfolio	of	spasticity	and	pain	
management drugs from UK-based specialty biopharmaceutical 
company Mallinckrodt Pharmaceuticals, in an all-cash deal for Rs. 
1160 crore (US$ 171 million).
•	 Aurobindo	Pharma	has	bought	Portugal	based	Generis	Farmaceutica	
SA, a generic drug company, for EUR 135 million (US$ 144 million).
•	 Sun	Pharmaceutical	Industries	Ltd.,	India’s	largest	drug	maker,	has	
entered into an agreement with Switzerland-based Novartis AG, to 
acquire the latter’s branded cancer drug Odomzo for around US$ 
175 million.
•	 Kedaara	Capital	Advisors	LLP,	a	PE	firm,	plans	to	invest	Rs.	430	crore	
(US$ 64.5 million) to acquire a minority stake in Hyderabad-based 
diagnostics chain Vijaya Diagnostic Centre Pvt. Ltd.
•	 Sun	Pharmaceuticals	Industries	Limited	plans	to	acquire	85.1%	stake	
in Russian company Biosintez for US$ 24 million for increasing its 
presence in Russia through local manufacturing capability.
•	 Abbott	Laboratories,	a	global	drug	maker,	based	in	the	US,	plans	to	set	
up an innovation and development center (I and D) in Mumbai, which 
will help in developing new drug formulations, new indications, 
dosing, packaging, and other differentiated offerings for Abbott’s 
global branded generics business.
Government initiatives
The implementation of the Goods and Services Tax is expected to be 
a game-changer for the Indian Pharmaceuticals industry. It will lead 
to tax neutral interstate transactions between two dealers, thereby 
reducing the dependency on multiple states and increasing the focus 
on regional hubs. It is expected to result in an efficient supply chain 
management, which is expected to reduce its cost considerably. The 
cost of technology and investment is expected to reduce on account of 
tax credit which can be availed now on the duties levied on import of 
costly machinery and equipment.
Some of the initiatives taken by the government to promote the 
pharmaceutical sector in India are as follows:
•	 In	the	Union	Budget	2017–2018,	the	Department	of	Biotechnology	
received Rs. 2222.11 crore (US$ 333.31 million), an increase of 22%, 
to continue implementing the department’s national biotech strategy.
•	 In	an	attempt	to	revive	the	active	pharmaceutical	ingredient	(API)	
and bulk drug market in India, the Government of India has proposed 
peak customs duty on the import of APIs and also plans to set up 
mega drug parks to give a boost to domestic production.
•	 The	Government	of	 India	unveiled	 “Pharma	Vision	2020”	aimed	
at making India a global leader in end-to-end drug manufacture. 
Approval time for new facilities has been reduced to boost 
investments.
•	 The	government	 introduced	mechanisms	such	as	 the	Drug	Price	
Control Order and the National Pharmaceutical Pricing Authority 
to deal with the issue of affordability and availability of medicines.
•	 Mr.	Ananth	Kumar,	Union	Minister	of	Chemicals	and	Petrochemicals,	
has announced setting up of chemical hubs across the country, early 
environment clearances in existing clusters, adequate infrastructure, 
and the establishment of a Central Institute of Chemical Engineering 
and Technology.
REVIEWS OF LITERATURE
Many researchers have studied working capital from different views 
and in different environments. The following study was very interesting 
and useful for our research.
Haresh [1] observed that a negative relationship between account 
receivables and corporate profitability and a positive relationship 
between accounts payable and profitability. The researcher concludes 
that the firms properly manage their cash, accounts receivables, 
accounts payables, and inventories in a proper way, will ultimately 
increase the profitability of these firms.
Bose [2] found that out of seven ratios (such as working capital 
turnover ratio, net current assets to total assets ratio, inventory 
turnover ratio, cash position ratio, and current ratio), only cash 
position ratio has positive influence on return on total assets and the 
remaining has a negative correlation with return on total assets and 
also found that return total assets is negatively associated with days 
of working capital.
Mogaka and Jagongo [3] found that the negative correlation between 
return on assets (ROA) and the firms average collection period (ACP) 
and cash conversion cycle (CCC) while the positive correlation with 
inventory holding period, accounts payment period. The authors 
conclude that working capital management has a significant impact on 
the profitability of the firms and play a key role in value creation for 
shareholders as large CCC have a negative impact on the profitability 
of firms. Ratio has a positive significant impact on ROA, and there is no 
significant impact of current ratio on ROA.
Bukhari and Malik [6] found that positive and insignificant relationship 
of ACP and profitability while the negative and insignificant relationship 
between profitability and average age of inventory and also found 
that the relationship between the average payment period (APP) 
and profitability is negative and significant. Moreover, the operating 
cycle has positively insignificant while CCC is positively significant 
relationship with profitability. The authors suggest that managers of 
these companies should spend more time to manage CCC of their firms 
and make strategies of efficient management of working capital. Above 
studies provide base and idea regarding working capital management 
and its components. However, these studies do not provide clear-
cut direction of the relationship between working capital and firms’ 
profitability. However, there are a few studies with reference to India 
on working capital management and firm profitability. Therefore, the 
present study is an attempt to fill this gap and estimates the relationship 
between working capital management variables (inventory conversion 
period (ICP), ACP, APP, and CCC) and profitability of firms in Indian 
Textile Industry.
OBJECTIVES OF THE STUDY
The major objective of the study is to examine the relationship between 
working capital management components and profitability of Cipla Ltd. 
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The present study is based on secondary data collected from secondary 
source (published annual report) named as 	 “CIPLA Ltd. then various 
issues of magazines and journals, working papers, and newspapers 
were also accessed for the relevant and covering the period from 
2012–2013 to 2016–2017 (5 years), as a part of study designed to an 
evaluation of profitability and working capital management of CIPLA 
Ltd., based on the following statistical tools were used: Summary 
statistics, correlation analysis, and t-test.
Variables explanation
In this study, we undertake profitability (ROA) as a dependent variable 
and the ICP, the ACP, the APP, and the CCC are used as independent 
variables and are considered for measuring working capital 
management. All the dependent and independent variables stated 
below have been used to test the hypotheses of the study.
ROA
Profitability is measured by ROA, which is defined as the ratio of 
earning after tax to total assets. ROA is used as a dependent variable. 
The ROA determines the management efficiency to use assets generates 
earnings. It is a better measure since it relates to the profitability of the 
company to the asset base.
ICP
ICP calculates how quickly the inventory is converted into sales. It is 
an excellent measure of the efficiency of the company in managing the 
Graph 1: Graph 4: 
Graph 5: Graph 2: 
Graph 3: Graph 6: 
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inventory. The important decision regarding inventory is that how much 
amount of cash should be tied up in inventory while meeting the other 
operations and functions of the business and demands of customers. It 
is calculated as 365/(Cost of goods sold/average inventory).
ACP
It is used as a proxy for the working capital collection policy is an 
independent variable. ACP is calculated by dividing trade debtors by 
sales and multiplying the result by 365. It indicates the time taken to 
collect cash from customers. The higher the value, the more will be the 
investment in account receivables.
APP
APP used as a proxy for the payment policy is also an independent 
variable. It is the time taken to pay the firms suppliers. The longer the 
time period the more advantageous for the firm so that funds can be put 
to other uses. It can be calculated as trade Paybles/(purchases/365).
CCC
Taking together ICP, ACP, and APP, CCC is calculated. It is used as a 
comprehensive measure of working capital management is another 
independent variable. It considers the amount of time to sell the 
inventory, collect the receivables and to pay bills. It is expected to have 
a negative relationship with profitability as a lower value of CCC shows 
less investments in current assets and also signifies higher liquidity, 
which easily converts its short-term investments in current assets to 
cash while higher value of CCC signifies greater investment in current 
assets and therefore shows the greater need for financing of current 
assets. It is calculated as adding ICP with ACP and deducting APP.
COMPANY PROFILE
CIPLA Ltd.
Cipla is a global pharmaceutical company whose goal is ensuring no 
patient shall be denied access to high quality and affordable medicine 
and support. Cipla’s journey began in 1935 when our founder, Dr. KA 
Hamied, set up an enterprise with the vision to make India self-
sufficient in health care. Over the past 77 years, they have emerged as 
one of the world’s most respected pharmaceutical names, not just in 
India but worldwide.
Cipla Limited is a holding company. The company is a pharmaceutical 
company. The company’s strategic business units include APIs, 
respiratory, and Cipla Global Access. The company’s geographical 
segments include India, USA, South Africa, and Rest of the World. The 
company manufactures metered dose inhalers, dry powder inhalers, 
nasal sprays, nebulizers, and a range of inhaled accessory devices. Cipla 
Global Access is a tender-based institutional business that concentrates 
on approximately four therapy areas: Human immunodeficiency 
virus (HIV)/AIDS, malaria, multidrug-resistant tuberculosis, and 
reproductive health. The company offers its products for the therapeutic 
areas, including cardiovascular, children’s health, dermatology and 
cosmetology, diabetes, HIV/AIDS, infectious diseases and critical 
care, malaria, neurosciences, oncology, ophthalmology, osteoporosis, 
respiratory, urology, and women’s health.
For patients, caring is a promise that they will do whatever it takes to 
ensure they have continued access to the highest quality medicines 
at affordable prices; whether a disease affects millions or just a few 
hundreds.
To the medical fraternity, caring means the assurance of world-class 
medicines and support across multiple therapeutic areas.
For business partners, caring brings the confidence of always getting 
world-class quality and competitive prices.
For employees, caring manifests itself in a safe, equal-opportunities’ 
workplace that fosters innovation for a healthier world.
DATA ANALYSIS AND INTERPRETATIONS
ROA=net profit/total assets
Return on asset ratio indicates the ratio of a firm’s Net profit to total 
assets. Total assets for the years 2012–2013, 2013–2014, 2014–
2015, 2015–2016, and 2016–2017 were Rs. 9826.36, Rs. 10,960.01, 
Rs. 12,461.79, Rs. 13,462.13, and Rs. 13,124.84 crore, respectively. 
Also, the net profit for the same period was Rs. 1507.11, Rs. 1388.34, 
Rs. 1181.09, Rs. 1398.03, and Rs. 974.94 crore, respectively. Table 1 
depicts the average net profit ratio as 11.06%. The growth rate of total 
assets	for	these	years	was	33.56%	and	that	of	net	profit	was	−35.31%.	
Total asset has been showing a constant increase every year except the 
year 2016–2017 but net profit ratio decrease every year during these 
period except 2015–2016. It shows the poor situation of the company.




Table 2 relates to correlation results of total assets and net profit. Karl 
Pearson coefficient of correlation was used to test the hypotheses at 
0.05 significant level between the net total assets and net profit with 
r=−0.63,	which	shows	a	moderate	degree	of	negative	correlation.	Hence,	
there is a significance relationship between net profit and total assets.
D.O.f--- (n–2)=5–2=3
n=5
Table value of t-test=3.182
Calculated value of t-test=1.41. 
The calculated value of t-test is 1.41 which is less than table value. Hence, 
null hypotheses are rejected and there is no significant relationship 
between net profit and total asset.
Inventory turnover ratio=cost of goods sold/average inventory
Inventory turnover ratio indicates the ratio of firm’s cost of goods sold 
to average inventory. Cost of goods sold for the years 2012–2013, 2013–
2014, 2014–2015, 2015–2016, and 2016–2017 was Rs. 3062.97, Rs. 
3760.62, Rs. 3981.10, Rs. 4899.25, and Rs. 4141. 30 crores, respectively. 
Furthermore, the average inventory for the same period was Rs. 
2343.37, Rs. 2427.265, Rs. 2900.18, Rs. 3103.835, and Rs. 2785.985 
crore, respectively. Table 3 depicts the average inventory turnover ratio 
as 145.448%. The growth rate of cost of goods sold for these years was 
35.20% and that of average inventory was 18.88%. The cost of goods 
sold has been showing a constant increase every year except 2016–
2017 but average inventory ratio increase and decrease every year 
during these period. It is a progressive situation of the company.
Table 2: Correlation results
Correlation Results
Karl Pearson coefficient of correlation −0.63
Year Net profit Total assets Ratio (%)
2012–2013 1507.11 9826.36 15.34
2013–2014 1388.34 10,960.01 12.67
2014–2015 1181.09 12,461.79 9.48
2015–2016 1398.03 13,462.13 10.38
2016–2017 974.94 13,124.84 7.43
Sources: Published annual report from 2012–2013 to 2016–2017
Statistical analysis
Arithmetic average 1289.902 11,967.026 11.06
Growth rate (%) −35.31 33.56
Table 1: 




ICP indicates about the average time to convert our total inventory into 
sales. It is the relationship between total days in year and inventory 
turnover ratio. In other words, it measures the length of time on average 
between the acquisition and sale of merchandise. ICP for the years 
2012–2013, 2013–2014, 2014–2015, 2015–2016, and 2016–2017 
was 279, 236, 270, 231, and 246 days, respectively. Table 4 depicts the 
average	ICP	as	252	days.	The	growth	rate	of	these	years	was	−11.83%.	
It is progressive situation of the company.




Table 5 relates to correlation results of ICP and net profit. Karl Pearson 
coefficient of correlation was used to test the hypotheses at 0.05 
significant level between the ICP and net profit with r=0.1089, which 
shows a low degree of positive correlation. Hence, there is a significant 
relationship between net profit and ICP.
D.O.f---	(n−2)	=5−2=3
n=5
Table value of t-test=3.182
Calculated value of t-test=0.1897.
The calculated value of t-test is 0.1897 which is less than table value. 
Hence, null hypotheses are accepted and there is no significant 
relationship between net profit and ICP.
ACP=(Average debtors/net credit sales)* 365
ACP indicates that the ACP is the average number of days required 
to collect invoiced amounts from customers. The measure is used to 
determine the effectiveness of a company’s credit granting policies 
and collection efforts. Net credit sale for the years 2012–2013, 2013–
2014, 2014–2015, 2015–2016, and 2016–2017 was Rs. 8042.40, 
Rs. 9075.84, Rs. 9738.94, Rs. 11,779.90, and Rs. 10,673.52 crores, 
respectively. Furthermore, the average debtor for the same period was 
Rs. 1645.22, Rs. 1686.66, Rs. 1893.505, Rs. 1978.825, Rs. 1918.765 
crore, respectively. Table 6 depicts the ACP as 68. The growth rate of 
net credit sale for these years was 32.72% and that of average debtor 
was 16.63 %. It is progressive in the collection process of the company.




Table 7 relates to correlation results of ACP and net profit. Karl Pearson 
coefficient of correlation was used to test the hypotheses at 0.05 
significant level between the ACP and net profit with r=0.2391, which 
shows a low degree of positive correlation. Hence, there is a significant 
relationship between net profit and ACP.
D.O.f---	(n−2)	=5−2=3
n=5
Table value of t-test=3.182
Calculated Value of t-test=0.43.
The calculated value of t-test is 0.43 which is less than the table 
value. Hence, null hypotheses are accepted and there is no significant 
relationship between net profit and ACP.
APP=(Average trade payable/net credit purchase)*365
APP indicates the average period taken by the company in making 
payments to its creditors. A shorter payment period indicates prompt 
payments to creditors. APP also indicates the creditworthiness of the 
company. Hence, a very short payment period may be an indication that 
the company is not taking full advantage of the credit terms allowed 
by suppliers. Net credit purchase for the years 2012–2013, 2013–
2014, 2014–2015, 2015–2016, and 2016–2017 was Rs. 2874.95, Rs. 
3155.01, Rs. 3828.51, Rs. 3465.65, and Rs. 2765.40 crore, respectively. 
Furthermore, the average creditor for the same period was Rs. 
827.09, Rs. 903.31, Rs. 1278.385, Rs. 1284.04, and Rs. 1144.525 crore, 
respectively. Table 8 depicts the APP as 124 days. The growth rate of net 
Table 5: Correlation results
Correlation Results
Karl Pearson coefficient of correlation 0.1089
Table 7: Correlation results
Correlation Results






2012–2013 1645.22 8042.40 75
2013–2014 1686.66 9075.84 68
2014–2015 1893.505 9738.94 71
2015–2016 1978.825 11,779.90 61
2016–2017 1918.765 10,673.52 66
Sources: Published annual report from 2012–2013 to 2016–2017
Statistical analysis
Arithmetic average 1824.595 9862.12 68
Growth rate (%) 16.63 32.72






Sources: Published annual report from 2012–2013 to 2016–2017
Statistical analysis
Arithmetic average (in days) 252
Growth rate (%) −11.83





2012–2013 3062.97 2343.37 130.71
2013–2014 3760.62 2427.265 154.93
2014–2015 3918.10 2900.18 135.1
2015–2016 4899.25 3103.835 157.85
2016–2017 4141.30 2785.985 148.65
Sources: Published annual report from 2012–2013 to 2016–2017
Statistical Analysis
Arithmetic average 3956.448 2712.127 145.448
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credit purchase for these years was 88.11% and that of average trade 
payable was 38.38%. It is consistency level maintain in payment to the 




Table 9 relates to the correlation results of APP and net profit. Karl 
Pearson coefficient of correlation was used to test the hypotheses at 
0.05	significant	level	between	the	APP	and	net	profit	with	r=−0.7785,	
which shows a high degree of negative correlation. Hence, there is a 
significant relationship between net profit and APP.
D.O.f---	(n−2)	=5−2=5
n=5
Table value of t-test=3.182
Calculated value of t-test=2.15.
The calculated value of t-test is 2.15 which is less than the table value. 
Hence, null hypotheses are accepted, and there is no significance 
relationship between net profit and APP.
CCC=(ICP+ACP−APP)
CCC indicates how many days it takes a company to receive cash from 
a customer from its initial cash outlay for inventory. Cash conversion 
period for the years 2012–2013, 2013–2014, 2014–2015, 2015–2016, 
and 2016–2017 was 249, 199, 219, 157, and 161 days, respectively. 
Table 10 depicts the average cash conversion period as 197 days. The 
growth rate of these years was 35.34%. It is progressive situation of 
the company.
Hypotheses 3:
H0:  There is no significant relationship between net profit and cash 
conversion period
Ha:	There	 is	 a	 significant	 relationship	between	net	profit	 and	 cash	
conversion period.
Table 11 relates to correlation results of cash conversion period and 
net profit. Karl Pearson coefficient of correlation was used to test the 
hypotheses at 0.05 significant level between the APP and net profit 
with r=0.4872, which shows a moderate degree of positive correlation. 




Table value of t-test=3.182
Calculated value of t-test=1.10524.
The calculated value of t-test is 1.10524 which is less than the table 
value. Hence, null hypotheses are accepted and there is no significant 
relationship between net profit and cash conversion period.
CONCLUSION
1. Haresh B. Working capital management and profitability: Evidence 
from India- an empirical study. GFJMR 2012;5:1-9.
2. Bose B. The impact of working capital management practices on firms 
profitability. Int J Appl Res Stud 2013;2:1-16.
3. Mogaka D, Jagongo A. Working capital management and firm 
profitability: Empirical evidence from manufacturing and construction 
firms listed on Nairobi securities exchange, Kenya. Int Account 
Taxation 2013;1:1-14.
4. Gitman LJ. Principles of Managerial Finance. 11th ed. USA: Pearson 
Education; 2005.
5. Agha H. Impact of working capital management on profitability. Eur 
Sci J 2014;10:374-81.
6. Bukhari M, Malik MS. The working capital management on corporate 
performance: A study of firms in cement, chemical and engineering 
sectors of Pakistan. Pak J Commer Soc Sci 2014;8:134-48.
Table 11: Correlation results
Correlation Results
Karl Pearson coefficient of correlation 0.4872
Table 9: Correlation results
Correlation Results
Karl Pearson coefficient of correlation −0.7785
Year ICP  ACP APP CCC (in days)
2012–2013 279 75 105 249
2013–2014 236 68 105 199
2014–2015 270 71 122 219
2015–2016 231 61 135 157
2016–2017 246 66  151 161
Sources: Published annual report from 2012–2013 to 2016–2017, 
ICP: Inventory conversion period, ACP: Average collection period, APP: Average 
payment period, CCC: Cash conversion cycle
Statistical analysis
Arithmetic average 252 68 124 197
Growth rate (%) 11.83 12 43.80 35.34





2012–2013 827.09 2874.95 105
2013–2014 903.31 3155.01 105
2014–2015 1278.385 3828.51 122
2015–2016 1284.04 3465.65 135
2016–2017 1144.525 2765.40 151
Sources: Published annual report from 2012–2013 to 2016–2017
Statistical Analysis
Arithmetic average 1087.47 3217.904 124
Growth rate (%) 38.38 −3.81
Table 10: Table 8: 
By observing the relationship between ROA and all other 
research variables that affect the firm’s profitability in the Cipla Ltd. 
through  the  correlation  test,  we  can  find  that  moderate  degree  of 
negative  correlation  and  insignificant  relationship  of  total  assets 
and profitability and also APP is high degree negative relationship 
with leverage but statistically insignificant. Even though, ICP and 
ACP were significant low degree positive related to profitability and
 CCC were significant moderate degree of positive relation. The results 
show that for overall Cipla Ltd., working capital management has a 
significant impact on the profitability of the firms. These results 
suggest that managers can create value for their shareholders by 
reducing the number of day’s accounts receivable and increasing the
 account payment period and inventories to a reasonable maximum 
and also suggests that managers of  these firms should spend  more 
time  to  manage  CCC  of  their  firms  and  make  strategies  of  efficient 
management of working capital. We may further conclude that these firm
 properly manage components of working capital such as cash, marketable
 securities, receivables, and inventory management should be explored, and 
their relationship with more proxies of profitability should be examined.
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